Ok Biotech Co Ltd (4155) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.100x

Based on the latest financial reports, Ok Biotech Co Ltd (4155) has a cash flow conversion efficiency ratio of 0.100x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$256.86 Million ≈ $8.09 Million USD) by net assets (NT$2.58 Billion ≈ $81.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Ok Biotech Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Ok Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Ok Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ok Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ok Biotech Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
TECO Image Systems Co Ltd
TWO:5438
-0.017x
Gray Television Inc
NYSE:GTN-A
0.000x
Loulis Mills S.A.
AT:KYLO
0.049x
Engenco Ltd
AU:EGN
0.101x
Golan Plastic
TA:GLPL
0.112x
Ramssol Group Bhd
KLSE:0236
0.028x
De Poan Pneumatic
TWO:1570
0.024x
China Fineblanking Technology Co Ltd
TWO:1586
0.013x

Annual Cash Flow Conversion Efficiency for Ok Biotech Co Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of Ok Biotech Co Ltd from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see Ok Biotech Co Ltd (4155) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 NT$2.58 Billion
≈ $81.16 Million
NT$319.57 Million
≈ $10.07 Million
0.124x +383.18%
2024-12-31 NT$2.57 Billion
≈ $80.87 Million
NT$65.90 Million
≈ $2.08 Million
0.026x +1996.54%
2023-12-31 NT$2.40 Billion
≈ $75.46 Million
NT$2.93 Million
≈ $92.41K
0.001x -99.06%
2022-12-31 NT$1.85 Billion
≈ $58.17 Million
NT$240.53 Million
≈ $7.58 Million
0.130x +913.18%
2021-12-31 NT$1.70 Billion
≈ $53.65 Million
NT$21.90 Million
≈ $689.84K
0.013x -84.86%
2020-12-31 NT$1.74 Billion
≈ $54.79 Million
NT$147.70 Million
≈ $4.65 Million
0.085x +144.78%
2019-12-31 NT$1.30 Billion
≈ $41.02 Million
NT$45.18 Million
≈ $1.42 Million
0.035x -65.83%
2018-12-31 NT$1.27 Billion
≈ $39.95 Million
NT$128.75 Million
≈ $4.06 Million
0.102x +19.16%
2017-12-31 NT$1.21 Billion
≈ $38.00 Million
NT$102.77 Million
≈ $3.24 Million
0.085x -69.12%
2016-12-31 NT$944.80 Million
≈ $29.77 Million
NT$260.72 Million
≈ $8.21 Million
0.276x -9.41%
2015-12-31 NT$950.15 Million
≈ $29.94 Million
NT$289.44 Million
≈ $9.12 Million
0.305x +864.81%
2014-12-31 NT$849.48 Million
≈ $26.76 Million
NT$-33.83 Million
≈ $-1.07 Million
-0.040x -127.88%
2013-12-31 NT$609.65 Million
≈ $19.21 Million
NT$87.08 Million
≈ $2.74 Million
0.143x -18.43%
2012-12-31 NT$452.10 Million
≈ $14.24 Million
NT$79.17 Million
≈ $2.49 Million
0.175x -42.99%
2011-12-31 NT$303.11 Million
≈ $9.55 Million
NT$93.12 Million
≈ $2.93 Million
0.307x +463.30%
2010-12-31 NT$230.78 Million
≈ $7.27 Million
NT$-19.52 Million
≈ $-614.83K
-0.085x -247.52%
2009-12-31 NT$121.25 Million
≈ $3.82 Million
NT$6.95 Million
≈ $218.96K
0.057x --

About Ok Biotech Co Ltd

TW:4155 Taiwan Medical Devices
Market Cap
$68.03 Million
NT$2.16 Billion TWD
Market Cap Rank
#20780 Global
#1272 in Taiwan
Share Price
NT$15.30
Change (1 day)
+0.00%
52-Week Range
NT$12.90 - NT$16.85
All Time High
NT$37.98
About

OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips. It also provides OTC hearing aids, multi-f… Read more